Alzheimer’s Drug Discovery Foundation Funds AgeneBio To Advance Pharmacological Neural Stabilizer Technology
Saturday, August 28th, 2010The Alzheimer’s Drug Discovery Foundation (ADDF) announced that it has awarded a grant of $240,000 to AgeneBio Inc. to develop a new class of small-molecules that have promise in treating amnestic mild cognitive impairment (aMCI), a neurological condition that often progresses to Alzheimer’s disease and affects more than 3 million ... continue reading